Literature DB >> 10765041

Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia.

Y Ji1, K Urakami, K Wada-Isoe, Y Adachi, K Nakashima.   

Abstract

The association between the estrogen receptor (ER-alpha) gene and dementia was examined in 223 patients with Alzheimer's disease (AD), 66 with vascular dementia (VD), 17 with alcohol-associated dementia (ALD) and 134 healthy elderly control subjects. The PvuII and XbaI restriction fragment length polymorphisms of the ER-alpha gene were represented as Pp (PvuII) and Xx (XbaI), with capital letters signifying the absence of restriction sites and small letters the presence of restriction sites. We found that the frequency of the ER-alpha gene P allele and X allele in the late-onset AD (LOAD) group (P allele was 0.51, X allele was 0.30) was significantly higher than that in controls (P 0.38, p < 0.01; X 0.20, p < 0.01), and that the frequency of the ER-alpha gene P allele and PP genotype was significantly different between apolipoprotein E epsilon4 carriers and noncarriers in LOAD. These findings suggest that the genotype of the ER-alpha gene may be specific in LOAD, and that the ER-alpha gene was an additional risk for LOAD. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10765041     DOI: 10.1159/000017224

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  21 in total

Review 1.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

Review 2.  A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.

Authors:  Erin E Sundermann; Pauline M Maki; Jeffrey R Bishop
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

3.  Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.

Authors:  Onofre Combarros; José Antonio Riancho; Jana Arozamena; Ignacio Mateo; Javier Llorca; Jon Infante; Pascual Sánchez-Juan; María Teresa Zarrabeitia; José Berciano
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

4.  Estrogen receptor-alpha variants increase risk of Alzheimer's disease in women with Down syndrome.

Authors:  Nicole Schupf; Joseph H Lee; Michelle Wei; Deborah Pang; Constance Chace; Rong Cheng; Warren B Zigman; Benjamin Tycko; Wayne Silverman
Journal:  Dement Geriatr Cogn Disord       Date:  2008-04-14       Impact factor: 2.959

5.  Viral vector-mediated delivery of estrogen receptor-alpha to the hippocampus improves spatial learning in estrogen receptor-alpha knockout mice.

Authors:  Thomas C Foster; Asha Rani; Ashok Kumar; Li Cui; Susan L Semple-Rowland
Journal:  Mol Ther       Date:  2008-07-01       Impact factor: 11.454

Review 6.  Polymorphisms in sex steroid receptors: From gene sequence to behavior.

Authors:  Donna L Maney
Journal:  Front Neuroendocrinol       Date:  2017-07-10       Impact factor: 8.606

7.  Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.

Authors:  Qi Zhao; Joseph H Lee; Deborah Pang; Alexis Temkin; Naeun Park; Sarah C Janicki; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Nicole Schupf
Journal:  Dement Geriatr Cogn Disord       Date:  2011-12-08       Impact factor: 2.959

Review 8.  Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging.

Authors:  Thomas C Foster
Journal:  Hippocampus       Date:  2011-04-27       Impact factor: 3.899

Review 9.  Hormonal treatment, mild cognitive impairment and Alzheimer's disease.

Authors:  Joanne Ryan; Jaqueline Scali; Isabelle Carriere; Karen Ritchie; Marie-Laure Ancelin
Journal:  Int Psychogeriatr       Date:  2008-02       Impact factor: 3.878

Review 10.  Estrogen receptors, the hippocampus, and memory.

Authors:  Linda A Bean; Lara Ianov; Thomas C Foster
Journal:  Neuroscientist       Date:  2014-02-07       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.